Health
FDA grants rare disease designations to investigational brain tumor drug – News-Medical.Net
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahom…
Reviewed by Emily Henderson, B.Sc.Sep 2 2020
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.
DIPG is a fast-growing pediatric cancer that starts in the brain stem. It is one of several sub-categories of malignant gliomas,…
-
Noosa News19 hours agoGirl, 15, rushed to hospital in life-threatening condition after being hit by car in Townsville
-
Noosa News19 hours agoNew Sci-Fi Drama ‘Pluribus’ Reunites ‘Breaking Bad’ Creator Vince Gilligan with ‘Better Call Saul’ Star Rhea Seehorn — and It Has a Teaser Trailer
-
Noosa News23 hours agoNeed for Feed Australia truck convoy hits Nullarbor for South Australia drought relief
-
General22 hours agoAdvance used unblurred footage of minors taken from education organisations without consent in new ad